Are we getting closer to using methotrexate in an optimal manner?

J Clin Oncol. 2011 Sep 1;29(25):3493-4; author reply 3494-5. doi: 10.1200/JCO.2011.37.0312. Epub 2011 Aug 1.

Authors

Barton A Kamen, Joseph R Bertino, John S Holcenberg, W Archie Bleyer

PMID: 21810689
DOI: 10.1200/JCO.2011.37.0312

No abstract available

Publication types

Letter
Comment

MeSH terms

Antimetabolites, Antineoplastic / administration & dosage*
Humans
Methotrexate / administration & dosage*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

Antimetabolites, Antineoplastic
Methotrexate